Non-Opioid Pain Patches Market Top Leading Players with Strategies and Forecast 2027

The global non-opioid pain patches market is estimated to grow at a CAGR of nearly 4.5% during the forecast period. The major factors driving the market growth include the increasing number of patients with neuropathic pain and rising prevalence of cancer. Neuropathic pain occurs due to injury or malfunction in the central or peripheral nervous system. Rising incidences of spinal cord injuries and diabetes are some major causes of neuropathic pain. As per the American Diabetes Association (ADA), nearly half of all people suffering from diabetes have some kind of nerve damage and is more common in the diabetic population who are living with this disease for several years.

To Request a Sample of our Report on Non-Opioid Pain Patches Market: https://www.omrglobal.com/request-sample/non-opioid-pain-patches-market

As of 2019, in the US, the estimated number of people with spinal cord injury is nearly 291,000. An estimated 78% of new incidences have witnessed among males. People suffering from spinal cord injury may suffer from several forms of pain which occurs in various areas of the body, such as neuropathic pain, musculoskeletal pain, and visceral pain. Spinal cord injury may result in damage to any part of the spine or nerve which causes abnormal communication between the nerves and this condition results in neuropathic pain. This contributes to the increasing demand for pain management techniques to reduce the amount of pain.

Lidocaine patches are used to provide relief from pain occurs due to post-herpetic neuralgia. It works by stopping nerves from transmitting pain signals. Rising prevalence of diabetic patients is further leading the demand for neuropathic pain management. Nerve damage is more common in the diabetic population, which results in the increasing prevalence of diabetic neuropathy. Owing to the rising prevalence of diabetic neuropathy, the non-opioid patch manufacturers are launching new products for potential relief from pain.

For instance, in December 2019, Averitas Pharma, Inc. declared the supplemental New Drug Application (sNDA) for QUTENZA (capsaicin 8% patch) to treat neuropathic pain associated with diabetic peripheral neuropathy. This is a major step forward for the company towards the goal of getting QUTENZA FDA approved for diabetic peripheral neuropathy. There are millions of patients suffering from painful diabetic peripheral neuropathy and looking for effective pain relief. These novel pipeline products are expected to offer an opportunity for the growth of the global non-opioid pain patches market.

(Get 15% Discount on Buying this Report)

A full Report of Non-Opioid Pain Patches Market is Available @ https://www.omrglobal.com/industry-reports/non-opioid-pain-patches-market

Global Non-Opioid Pain Patches Market- Segmentation

By Patch Type

· Lidocaine Patches

· Diclofenac Patches

· Capsaicin Patches

· Others

By Distribution Channel

· Hospitals

· Online Pharmacies

· Drug Stores

Global Non-Opioid Pain Patches Market- Segment by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Company Profiles

· Acorda Therapeutics, Inc.

· AdhexPharma

· Alkermes plc

· Averitas Pharma, Inc.

· BioElectronics Corp.

· Ceramisphere Pty Ltd.

· Endo International plc

· GlaxoSmithKline plc

· Hisamitsu Pharmaceutical Co., Inc.

· IBSA Institut Biochimique SA

· Mylan N.V.

· Pfizer Inc.

· Sanofi S.A.

· Sorrento Therapeutics, Inc.

· TEH SENG Pharmaceutical Mfg. Co., Ltd.

· Teikoku Seiyaku Co. Ltd.

· Teva Pharmaceuticals Industries Ltd.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.